From drug crises to regulatory change: The mediation of expertise

Health, Risk and Society

Volumn 10, Issue 1, 2008, Pages 37-51

  Demortain, David ^a  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

Author keywords

Cerivastatin; Expertise; Framing; Medicines safety; Post marketing surveillance; Regulatory change; Regulatory crisis; Regulatory failure

Indexed keywords

BENOXAPROFEN; CERIVASTATIN; FENOTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PRACTOLOL; SULFANILAMIDE; THALIDOMIDE;

ACCIDENT; ARTICLE; CONSENSUS; DISASTER; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; ELIXIR; FATALITY; FOOD AND DRUG ADMINISTRATION; HEALTH CARE PLANNING; HEALTH CARE POLICY; HUMAN; PHARMACOEPIDEMIOLOGY; POLITICAL SYSTEM; POSTMARKETING SURVEILLANCE; RISK MANAGEMENT;

EID: 39049169747     PISSN: 13698575     EISSN: 14698331     Source Type: Journal    
DOI: 10.1080/13698570701782437     Document Type: Article

References (47)

1. Abbott, A. (1988) The System of Professions: Essay on the Division of Expert Labour, Chicago University Press, Chicago
2. Abraham, J. and Davis, C. (2006) Testing times: The emergence of the practalol disaster and its challenge to British drug regulation in the modern period. Social History of Medicine, 19, pp. 127-147.
3. Alink, F., Boin, A. and t'Hart, P. (2001) Institutional crises and reforms in policy sectors: The case of asylum policy in Europe. Journal of European Public Policy, 8, pp. 286-306.
4. Baldwin, R. (2000) Is Regulation Right? Discussion Paper of the Centre for Analysis of Risk and Regulation, LSE, London
5. Bevir, M. and Rhodes, R. (1999) Studying British government: reconstructing the research agenda. The British Journal of Politics and International Relations, 1, pp. 215-239.
6. Boin, A. and t'Hart, P. (2000) Institutional crises and reforms in policy sectors. Government Institutions: Effects, Changes and Normative Foundations, pp. 9-31. Kluwer Academic Publishers, Boston
7. Boin, A. and t'Hart, P. (2003) Public leadership in times of crisis: mission impossible?. Public Administration Review, 63, pp. 544-553.
8. Boin, A. and Otten, M. (1996) Beyond the crisis window for reform: Some ramifications for implementation. Journal of Contingencies and Crisis Management, 4, pp. 149-161.
9. Bovens, M. and t'Hart, P. (1996) Understanding Policy Fiascos, Transaction Publishers, New Brunswick, NJ
10. Bröndström, A. and Kuipers, S. (2003) From 'normal incidents' to political crises: Understanding the selective politicization of policy failures. Government and Opposition, 38, pp. 279-305.
11. Brynner, R. and Stephens, T. (2001) Dark Remedy. The Impact of Thalidomide and its Revival as a Vital Medicine, Perseus Publishing, Cambridge
12. Cohen, M., March, J. and Olsen, J. (1972) A garbage can model of organizational choice. Administrative Science Quarterly, 17, pp. 1-25.
13. de Vries, M. (2004) Framing crises: Response patterns to explosions in fireworks factories. Administration & Society, 36, pp. 594-614.
14. Demortain, D. (2006) Mettre les risques sous surveillance. L'outillage de la sécurité sanitaire des médicaments et des aliments en Europe, Ecole Normale Supérieure of Cachan
15. Dobry, M. (1992) Sociologie des crises politiques: La dynamique des mobilisations multisectorielles, Presses de la Fondation nationale des sciences politiques, Paris
16. Edwards, R. (1997) Who cares about pharmacovigilance. European Journal of Clinical Pharmacology, 53, pp. 83-88.
17. FDA (1999) Managing the Risks from Medical Product Use. Creating a Risk Management Framework, Report to the FDA Commissioner from the Task Force on Risk Management, US Department of Health and Human Services, Washington
18. Gains, F. (2004) Hardware, software or network connection? Theorizing crisis in the UK next steps agencies?. Public Administration, 82, pp. 547-566.
19. Gilbert, C. and Henry, E. (2006) Divergences or complementarity within the research into crises in France?. International Journal of Emergency Management, 3, pp. 5-11.
20. Haas, P. (1992) Introduction: Epistemic communities and international policy coordination. International Organization, 46, pp. 1-35.
21. Hancher, L. and Moran, M. (1989) Organizing regulatory space. Capitalism, Culture and Regulation, Clarendon Press, Oxford
22. Harris, R. and Milkis, S. (1996) The Politics of Regulatory Change. A Tale of Two Agencies, Oxford University Press, New York and Oxford
23. Hay, C. and Richards, D. (2000) The tangled webs of Westminster and Whitehall: The discourse, strategy and practice of networking within the British core executive. Public Administration, 78, pp. 1-28.
24. HoA (2003) Establishing a European risk management strategy. Summary report of the Heads of Agencies ad hoc working group, MCA/PL/JM/HoA/ Summary report
25. Hood, C. and Lodge, M. (2005) Pavlovian innovation, pet solutions and economizing on rationality? Politicians and dangerous dogs. Regulatory Innovation: A Comparative Analysis, pp. 138-155. Edward Elgar, North Hampton, MA
26. Hood, C., Rothstein, H. and Baldwin, R. (2001) The Government of Risk. Understanding Risk Regulation Regimes, Oxford University Press, Oxford
27. Hutter, B. (2001) Risk and Regulation: Occupational Health and Safety on the Railways, Oxford University Press, New York
28. Keeler, J. T. S. (1993) Opening the Window for Reform: Mandates, Crises, and Extraordinary Policy-Making. Comparative Political Studies, 25, pp. 433-486.
29. Kingdon, J. (1984) Agendas, Alternatives and Public Policies, Little Brown, Boston
30. Lindquist, M. (2003) Seeing and Observing in International Pharmacovigilance. Achievements and Prospects in Worldwide Drug Safety, Uppsala Monitoring Centre, Uppsala
31. Lodge, M. (2002) The wrong type of regulation? Regulatory failure and the railways in Britain and Germany. Journal of Public Policy, 22, pp. 271-297.
32. Moran, M. (2001) Not steering but drowning: Policy catastrophes and the regulatory state. The Political Quarterly, 72, pp. 414-427.
33. Nelson, R. (2000) We need a postmarketing drug development process!. Pharmacoepidemiology and Drug Safety, 9, pp. 253-255.
34. Nohrstedt, D. (2007) Crisis and Policy Reformcraft: Advocacy Coalitions and Crisis-induced Change in Swedish Nuclear Energy Policy, Uppsala University
35. Parsons, W. (1995) Public Policy: An Introduction to the Theory and Practice of Policy Analysis, Edward Elgar, Aldershot
36. Quirk, P. (1980) Food and drug administration. The Politics of Regulation, pp. 191-235. Basic Books, New York
37. Sabatier, P. and Jenkins-Smith, H. (1993) Policy Change and Learning: An Advocacy Coalition Approach, Westview Press, Boulder and San Francisco
38. Selznick, P. (1985) Focussing organizational research on regulation. Regulatory Policy and the Social Sciences, pp. 363-367. University of California Press, Berkeley & Los Angeles
39. Snow, D. and Benford, R. (1988) Ideology, frame resonance, and participant mobilization. International Social Movement Research, 1, pp. 197-217.
40. Snow, D., Rochford, E. Burke, Worden, S. and Benford, R. (1986) Frame alignment processes, micromobilization, and movement participation. American Sociological Review, 51, pp. 464-481.
41. Stern, E. (1997) Crisis and learning: A conceptual balance sheet. Journal of Contingencies and Crisis Management, 5, pp. 69-86.
42. Temin, P. (1980) Taking your Medicine. Drug Regulation in the United States, Harvard University Press, Boston
43. Temin, P. (1985) Government action in times of crisis: Lessons from the history of drug regulation. Journal of Social History, 18, pp. 433-438.
44. Timmermans, S. and Berg, M. (1997) Standardization in action: Achieving local universality through medical protocols. Social Studies of Science, 27, pp. 273-305.
45. Waller, P. and Evans, S. (2002) A model for the future conduct of pharmacovigilance. Pharmacoepidemiology and Drug Safety, 10, pp. 773-786.
46. Wilson, C. A. (2000) Policy regimes and policy change. Journal of Public Policy, 20, pp. 247-274.
47. Wilson, J. (1980) The politics of regulation. The Politics of Regulation, pp. 357-394. Basic Books, New York